Cargando…

Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda

BACKGROUND: The acute form of Human African Trypanosomiasis (HAT, also known as Sleeping sickness) caused by Trypanosoma brucei rhodesiense has been shown to have a wide spectrum of focus specific clinical presentation and severity in East and Southern Africa. Indeed HAT occurs in regions endemic fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Charles D., Nanteza, Ann, Mugasa, Claire, Edyelu, Andrew, Matovu, Enock, Alibu, Vincent P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342333/
https://www.ncbi.nlm.nih.gov/pubmed/25719539
http://dx.doi.org/10.1371/journal.pone.0118370
_version_ 1782359268763107328
author Kato, Charles D.
Nanteza, Ann
Mugasa, Claire
Edyelu, Andrew
Matovu, Enock
Alibu, Vincent P.
author_facet Kato, Charles D.
Nanteza, Ann
Mugasa, Claire
Edyelu, Andrew
Matovu, Enock
Alibu, Vincent P.
author_sort Kato, Charles D.
collection PubMed
description BACKGROUND: The acute form of Human African Trypanosomiasis (HAT, also known as Sleeping sickness) caused by Trypanosoma brucei rhodesiense has been shown to have a wide spectrum of focus specific clinical presentation and severity in East and Southern Africa. Indeed HAT occurs in regions endemic for other tropical diseases, however data on how these co-morbidities might complicate the clinical picture and affect disease outcome remains largely scanty. We here describe the clinical presentation, presence of co-infections, and how the latter impact on HAT prognosis. METHODS AND FINDINGS: We carried out a retrospective analysis of clinical data from 258 sleeping sickness patients reporting to Lwala hospital between 2005 and 2012. The mean patient age was 28.6 years with a significant number of cases below 18 years (p< 0.0001). About 93.4% of the cases were diagnosed as late stage (p< 0.0001). The case fatality rate was 10.5% with post treatment reactive encephalopathys reported in 7.9% of the cases, of whom 36.8% eventually died. Fever was significantly (p = 0.045) higher in patients under 18 years. Of the early stage patients, 26.7% and 6.7% presented with late stage signs of sleep disorder and mental confusion respectively. Among the co-infections, malaria was significantly more prevalent (28.9%; p< 0.0001) followed by urinary tract infections (4.2%). Co-infections were present in 14.3% of in-hospital deaths, 38.5% of which were recorded as Malaria. Malaria was significantly more common in patients under 18 years (45.5%; p< 0.02), and was reported in 60% of the fatal cases in this age group. CONCLUSIONS: We show a wide spectrum of sleeping sickness clinical presentation and disease outcome that was apparently not significantly influenced by concurrent infections. It would thus be interesting to determine the host and/or parasite factors that might be responsible for the observed diverse clinical presentation.
format Online
Article
Text
id pubmed-4342333
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43423332015-03-04 Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda Kato, Charles D. Nanteza, Ann Mugasa, Claire Edyelu, Andrew Matovu, Enock Alibu, Vincent P. PLoS One Research Article BACKGROUND: The acute form of Human African Trypanosomiasis (HAT, also known as Sleeping sickness) caused by Trypanosoma brucei rhodesiense has been shown to have a wide spectrum of focus specific clinical presentation and severity in East and Southern Africa. Indeed HAT occurs in regions endemic for other tropical diseases, however data on how these co-morbidities might complicate the clinical picture and affect disease outcome remains largely scanty. We here describe the clinical presentation, presence of co-infections, and how the latter impact on HAT prognosis. METHODS AND FINDINGS: We carried out a retrospective analysis of clinical data from 258 sleeping sickness patients reporting to Lwala hospital between 2005 and 2012. The mean patient age was 28.6 years with a significant number of cases below 18 years (p< 0.0001). About 93.4% of the cases were diagnosed as late stage (p< 0.0001). The case fatality rate was 10.5% with post treatment reactive encephalopathys reported in 7.9% of the cases, of whom 36.8% eventually died. Fever was significantly (p = 0.045) higher in patients under 18 years. Of the early stage patients, 26.7% and 6.7% presented with late stage signs of sleep disorder and mental confusion respectively. Among the co-infections, malaria was significantly more prevalent (28.9%; p< 0.0001) followed by urinary tract infections (4.2%). Co-infections were present in 14.3% of in-hospital deaths, 38.5% of which were recorded as Malaria. Malaria was significantly more common in patients under 18 years (45.5%; p< 0.02), and was reported in 60% of the fatal cases in this age group. CONCLUSIONS: We show a wide spectrum of sleeping sickness clinical presentation and disease outcome that was apparently not significantly influenced by concurrent infections. It would thus be interesting to determine the host and/or parasite factors that might be responsible for the observed diverse clinical presentation. Public Library of Science 2015-02-26 /pmc/articles/PMC4342333/ /pubmed/25719539 http://dx.doi.org/10.1371/journal.pone.0118370 Text en © 2015 Kato et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kato, Charles D.
Nanteza, Ann
Mugasa, Claire
Edyelu, Andrew
Matovu, Enock
Alibu, Vincent P.
Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda
title Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda
title_full Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda
title_fullStr Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda
title_full_unstemmed Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda
title_short Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda
title_sort clinical profiles, disease outcome and co-morbidities among t. b. rhodesiense sleeping sickness patients in uganda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342333/
https://www.ncbi.nlm.nih.gov/pubmed/25719539
http://dx.doi.org/10.1371/journal.pone.0118370
work_keys_str_mv AT katocharlesd clinicalprofilesdiseaseoutcomeandcomorbiditiesamongtbrhodesiensesleepingsicknesspatientsinuganda
AT nantezaann clinicalprofilesdiseaseoutcomeandcomorbiditiesamongtbrhodesiensesleepingsicknesspatientsinuganda
AT mugasaclaire clinicalprofilesdiseaseoutcomeandcomorbiditiesamongtbrhodesiensesleepingsicknesspatientsinuganda
AT edyeluandrew clinicalprofilesdiseaseoutcomeandcomorbiditiesamongtbrhodesiensesleepingsicknesspatientsinuganda
AT matovuenock clinicalprofilesdiseaseoutcomeandcomorbiditiesamongtbrhodesiensesleepingsicknesspatientsinuganda
AT alibuvincentp clinicalprofilesdiseaseoutcomeandcomorbiditiesamongtbrhodesiensesleepingsicknesspatientsinuganda